- Home
- PRLD vs AIRE Comparison
PRLD vs AIRE Comparison
Compare PRLD & AIRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- AIRE
- Stock Information
- Founded
- PRLD 2016
- AIRE 2021
- Country
- PRLD United States
- AIRE United States
- Employees
- PRLD N/A
- AIRE N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- AIRE
- Sector
- PRLD Health Care
- AIRE
- Exchange
- PRLD Nasdaq
- AIRE Nasdaq
- Market Cap
- PRLD 44.0M
- AIRE 39.4M
- IPO Year
- PRLD 2020
- AIRE N/A
- Fundamental
- Price
- PRLD $1.03
- AIRE $1.19
- Analyst Decision
- PRLD Strong Buy
- AIRE Hold
- Analyst Count
- PRLD 3
- AIRE 1
- Target Price
- PRLD $4.00
- AIRE N/A
- AVG Volume (30 Days)
- PRLD 231.3K
- AIRE 32.0M
- Earning Date
- PRLD 11-05-2025
- AIRE 11-11-2025
- Dividend Yield
- PRLD N/A
- AIRE N/A
- EPS Growth
- PRLD N/A
- AIRE N/A
- EPS
- PRLD N/A
- AIRE N/A
- Revenue
- PRLD $7,000,000.00
- AIRE $3,043,657.00
- Revenue This Year
- PRLD N/A
- AIRE $410.32
- Revenue Next Year
- PRLD N/A
- AIRE $166.28
- P/E Ratio
- PRLD N/A
- AIRE N/A
- Revenue Growth
- PRLD N/A
- AIRE 2973.28
- 52 Week Low
- PRLD $0.61
- AIRE $0.14
- 52 Week High
- PRLD $2.72
- AIRE $4.49
- Technical
- Relative Strength Index (RSI)
- PRLD 45.61
- AIRE 72.30
- Support Level
- PRLD $1.03
- AIRE $1.13
- Resistance Level
- PRLD $1.26
- AIRE $1.42
- Average True Range (ATR)
- PRLD 0.11
- AIRE 0.19
- MACD
- PRLD -0.03
- AIRE 0.08
- Stochastic Oscillator
- PRLD 10.34
- AIRE 57.72
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About AIRE reAlpha Tech Corp.
ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are; Platform Services and the Rental business segment.